Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System

PURPOSE: Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic tumors treated in the public health system in Brazil do not have access to trastuzumab. This study aimed to estimate the impact of the lack of access to anti-HER2 therapies on the mortality of these patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Debiasi, Márcio, Reinert, Tomás, Kaliks, Rafael, Amorim, Gilberto, Caleffi, Maira, Sampaio, Carlos, Fernandes, Gustavo dos Santos, Barrios, Carlos H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493223/
https://www.ncbi.nlm.nih.gov/pubmed/28717761
http://dx.doi.org/10.1200/JGO.2016.005678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493223/
https://www.ncbi.nlm.nih.gov/pubmed/28717761
http://dx.doi.org/10.1200/JGO.2016.005678

Ejemplares similares